Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Increased alpha-B-crystallin expression in mammary metaplastic carcinomas.

Chan SK, Lui PC, Tan PH, Yamaguchi R, Moriya T, Yu AM, Shao MM, Hliang T, Wong SI, Tse GM.

Histopathology. 2011 Aug;59(2):247-55. doi: 10.1111/j.1365-2559.2011.03882.x.

PMID:
21884203
2.

AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas.

Sitterding SM, Wiseman WR, Schiller CL, Luan C, Chen F, Moyano JV, Watkin WG, Wiley EL, Cryns VL, Diaz LK.

Ann Diagn Pathol. 2008 Feb;12(1):33-40. doi: 10.1016/j.anndiagpath.2007.02.004. Epub 2007 Oct 24.

PMID:
18164413
3.

p63 is useful in the diagnosis of mammary metaplastic carcinomas.

Tse GM, Tan PH, Chaiwun B, Putti TC, Lui PC, Tsang AK, Wong FC, Lo AW.

Pathology. 2006 Feb;38(1):16-20.

PMID:
16484002
4.

Metaplastic breast carcinomas and their relationship with basal-like phenotype.

Cakir A, Gönül II, Uluoğlu O.

Turk Patoloji Derg. 2012;28(2):134-41. doi: 10.5146/tjpath.2012.01112.

5.

May metaplastic breast carcinomas be actually basal-like carcinoma? Further evidence study with its ultrastructure and survival analysis.

Wang H, Guan B, Shi Q, Ma H, Zhou H, Wang X, Zhou X.

Med Oncol. 2011 Mar;28(1):42-50. doi: 10.1007/s12032-009-9399-1. Epub 2009 Dec 30.

PMID:
20041316
6.

Metaplastic breast carcinomas are basal-like tumours.

Reis-Filho JS, Milanezi F, Steele D, Savage K, Simpson PT, Nesland JM, Pereira EM, Lakhani SR, Schmitt FC.

Histopathology. 2006 Jul;49(1):10-21.

PMID:
16842242
7.

Laminin 5 expression in metaplastic breast carcinomas.

Carpenter PM, Wang-Rodriguez J, Chan OT, Wilczynski SP.

Am J Surg Pathol. 2008 Mar;32(3):345-53. doi: 10.1097/PAS.0b013e3181592201. Erratum in: Am J Surg Pathol. 2009 Feb;33(2):322.

PMID:
18300817
8.

Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma.

Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Maeda I, Tsuchiya S, Yamaguchi M, Takahashi R, Ogata Y, Abe H, Akiba J, Nakashima O, Kage M, Yano H.

Med Mol Morphol. 2012 Dec;45(1):14-21. doi: 10.1007/s00795-010-0536-x. Epub 2012 Mar 20.

PMID:
22431179
9.

alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.

Ivanov O, Chen F, Wiley EL, Keswani A, Diaz LK, Memmel HC, Rademaker A, Gradishar WJ, Morrow M, Khan SA, Cryns VL.

Breast Cancer Res Treat. 2008 Oct;111(3):411-7. Epub 2007 Oct 30.

PMID:
17968656
10.
11.

Metaplastic carcinoma of the breast: a clinicopathological review.

Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK.

J Clin Pathol. 2006 Oct;59(10):1079-83. Epub 2006 Feb 7.

12.

[Pathologic diagnosis and differential diagnosis of low-grade adenosquamous carcinoma of breast and syringomatous adenoma of nipple].

Li J, Yang GZ, Jin H, Ding HY.

Zhonghua Bing Li Xue Za Zhi. 2012 May;41(5):301-4. doi: 10.3760/cma.j.issn.0529-5807.2012.05.004. Chinese.

PMID:
22883667
13.

Metaplastic breast carcinoma: pathology and clinical outcome.

Bellino R, Arisio R, D'Addato F, Attini R, Durando A, Danese S, Bertone E, Grio R, Massobrio M.

Anticancer Res. 2003 Jan-Feb;23(1B):669-73.

PMID:
12680165
14.

Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy.

Kabbage M, Trimeche M, Ben Nasr H, Hammann P, Kuhn L, Hamrita B, Chaieb A, Chouchane L, Chahed K.

Tumour Biol. 2012 Dec;33(6):2279-88. doi: 10.1007/s13277-012-0490-4. Epub 2012 Sep 13.

PMID:
22972503
15.

αB-crystallin is a useful marker for triple negative and basal breast cancers.

Tsang JY, Lai MW, Wong KH, Chan SK, Lam CC, Tsang AK, Yu AM, Tan PH, Tse GM.

Histopathology. 2012 Sep;61(3):378-86. doi: 10.1111/j.1365-2559.2012.04234.x. Epub 2012 Mar 28.

PMID:
22463677
16.

p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.

Koker MM, Kleer CG.

Am J Surg Pathol. 2004 Nov;28(11):1506-12.

PMID:
15489655
17.

Mesothelial markers in high-grade breast carcinoma.

Duhig EE, Kalpakos L, Yang IA, Clarke BE.

Histopathology. 2011 Nov;59(5):957-64. doi: 10.1111/j.1365-2559.2011.04036.x.

PMID:
22092407
18.

ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.

Pelosi G, Rossi G, Cavazza A, Righi L, Maisonneuve P, Barbareschi M, Graziano P, Pastorino U, Garassino M, de Braud F, Papotti M.

Int J Surg Pathol. 2013 Jun;21(3):229-39. doi: 10.1177/1066896913476750. Epub 2013 Mar 12.

PMID:
23486764
19.

Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.

Geyer FC, Lambros MB, Natrajan R, Mehta R, Mackay A, Savage K, Parry S, Ashworth A, Badve S, Reis-Filho JS.

Mod Pathol. 2010 Jul;23(7):951-60. doi: 10.1038/modpathol.2010.82. Epub 2010 May 7.

20.

Expression of p40 and laminin 332 in metaplastic spindle cell carcinoma of the breast compared with other malignant spindle cell tumours.

D'Alfonso TM, Ross DS, Liu YF, Shin SJ.

J Clin Pathol. 2015 Jul;68(7):516-21. doi: 10.1136/jclinpath-2015-202923. Epub 2015 Mar 20.

PMID:
25795733
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk